Primary systemic therapy of ovarian cancer

被引：0

作者：

Pfisterer, J. ^{[1
]}

Hilpert, F. ^{[2
]}

Mahner, S. ^{[3
]}

Harter, P. ^{[4
]}

du Bois, A. ^{[4
]}

机构：

[1] Zentrum Gynakol Onkol Kiel, Herzog Friedrich Str 21, D-24103 Kiel, Germany

[2] Univ Klinikum Schleswig Holstein, Klin Gynakol & Geburtshilfe, Kiel, Germany

[3] Univ Klinikum Hamburg Eppendorf, Klin Gynakol, Hamburg, Germany

[4] Kliniken Essen Mitte, Klin Gynakol & Gynakol Onkol, Essen, Germany

来源：

GYNAKOLOGE | 2013年 / 46卷 / 08期

关键词：

Chemotherapy; Bevacizumab; Metastases; Angiogenesis inhibition; Targeted therapy;

D O I：

10.1007/s00129-012-3113-7

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Standard primary systemic treatment of patients with advanced ovarian cancer comprises six courses of intravenously administered carboplatin and paclitaxel. In patients with FIGO stage IIIB-IV disease, additional treatment with bevacizumab is possible. Primary, neoadjuvant treatment without prior debulking surgery should be avoided. Intraperitoneal treatments, including HIPEC, should only be given within controlled clinical trials.

引用

页码：541 / 546

页数：6

共 50 条

[1] Systemic therapy of advanced primary ovarian cancer
Costa, SD
Möbus, V
Meden, H
[J]. GYNAKOLOGE, 2002, 35 (05): : 458 - 464
[2] Landscape of systemic therapy for ovarian cancer in 2019: Primary therapy
Fujiwara, Keiichi
Hasegawa, Kosei
Nagao, Shoji
[J]. CANCER, 2019, 125 : 4582 - 4586
[3] Systemic treatment of primary ovarian cancer
Selcuk, Ilker
Yaznil, Muhammad Rizki
[J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : 5 - 6
[4] Primary Therapy of Ovarian Cancer
Hasenburg, A.
[J]. GYNAKOLOGE, 2018, 51 (08): : 598 - 598
[5] Primary systemic therapy of ovarian cancer [Primäre systemtherapie des ovarialkarzinoms]
Pfisterer J.
Hilpert F.
Mahner S.
Harter P.
Du Bois A.
[J]. Der Gynäkologe, 2013, 46 (8): : 541 - 546
[6] Biomarkers for Systemic Therapy in Ovarian Cancer
Penzvalto, Zsofia
Surowiak, Pawel
Gyorffy, Balazs
[J]. CURRENT CANCER DRUG TARGETS, 2014, 14 (03) : 259 - 273
[7] Optimal primary therapy of ovarian cancer
Bookman, M. A.
[J]. ANNALS OF ONCOLOGY, 2016, 27 : 58 - 62
[8] Management of recurrent ovarian cancer with systemic therapy
Poveda, Andres
[J]. EJC SUPPLEMENTS, 2007, 5 (01): : 29 - 36
[9] Ovarian cancer - New insights into systemic therapy
Neijt, JP
[J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 296 - 296
[10] New Issues in Systemic Therapy for Ovarian Cancer
Armstrong, Deborah K.
[J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (5.5): : 690 - 693

← 1 2 3 4 5 →